Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15635)	2/22/1998 9:05:00 PM
From: WTDEC	Respond to of 32384

Henry, thanks for the quick response. I too am quite confident that LGND is on track to file the NDA sooner rather than later this quarter. Good point that most biotechs don't draw people with the depth of experience that LGND did.....adds to my concern when looking at other biotechs. Anyone else have any insights into the process of preparing a NDA? Regards, wtd PS: Glad to see soccer comments back. Good luck this season.

To: Henry Niman who wrote (15635)	2/22/1998 9:50:00 PM
From: RXGOLF	Read Replies (2) \| Respond to of 32384

<wtd, NDA applications are really out of my area, but they are not out of LGND's. Unlike most Biotechs, LGND drew almost exclusively from the big Pharmas for senior management (I think that the 1995 Annual Report indicated that senior management had brought over 40 multi-million dollar drugs to market).> After what happened at DEPO a while back, this now seems very important. What happened to those investors would be hard to swallow, and I can't help but think stronger management might have helped! With the experience that Ligand brings to the table, I would hope that the NDA would come off without incident. RXGOLF